Patent application number | Description | Published |
20100159450 | DPYD GENE VARIANTS AND USE THEREOF - Variants in DPYD gene are disclosed which can result in abnormal synthesis of DPD proteins and alteration of DPD activities. The invention provides methods for detecting the newly discovered genetic variants. The DPD genetic variants of the invention can be used as biomarkers in predicting toxicity to 5-FU and other drugs metabolized by the DPD enzyme. | 06-24-2010 |
20110311972 | DPYD GENE VARIANTS AND USE THEREOF - Variants in DPYD gene are disclosed which can result in abnormal synthesis of DPD proteins and alteration of DPD activities. The invention provides methods for detecting the newly discovered genetic variants. The DPD genetic variants of the invention can be used as biomarkers in predicting toxicity to 5-FU and other drugs metabolized by the DPD enzyme. | 12-22-2011 |
20120041274 | CANCER BIOMARKERS - Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided. | 02-16-2012 |
20120309018 | CANCER DETECTION MARKERS - Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided. | 12-06-2012 |
20130005610 | TOXICITY-ASSOCIATED GENES, GENETIC VARIANTS, AND USE THEREOF - Genes and genetic variants in human genomes are disclosed which are useful, inter alia, as diagnostic biomarkers. | 01-03-2013 |
20130058924 | HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION - Biomarkers, particularly hypoxia-related genes, and methods using the biomarkers for molecular detection and classification of disease are provided. | 03-07-2013 |
20130143747 | METHODS OF DETECTING CANCER - Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided. | 06-06-2013 |
20130302242 | GENE SIGNATURES FOR CANCER DIAGNOSIS AND PROGNOSIS - Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided. | 11-14-2013 |
20140113310 | CANCER DETECTION MARKERS - Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided. | 04-24-2014 |
20140134166 | HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION - Biomarkers, particularly hypoxia-related genes, and methods using the biomarkers for molecular detection and classification of disease are provided. | 05-15-2014 |
20140170139 | HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION - Biomarkers, particularly hypoxia-related genes, and methods using the biomarkers for molecular detection and classification of disease are provided. | 06-19-2014 |
20140170242 | GENE SIGNATURES FOR LUNG CANCER PROGNOSIS AND THERAPY SELECTION - The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof. | 06-19-2014 |
20140212415 | HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION - Biomarkers, particularly hypoxia-related genes, and methods using the biomarkers for molecular classification of disease are provided. | 07-31-2014 |
20140315935 | GENE SIGNATURES FOR LUNG CANCER PROGNOSIS AND THERAPY SELECTION - The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof. | 10-23-2014 |